Skip to main content
. 2015 Dec 10;33(4):260–268. doi: 10.3109/02813432.2015.1117281

Figure 1.

Figure 1.

Optimal prescription rates (both lipid-lowering and antithrombotic drugs) depending on age, sex, GPs’ judgement of vulnerability, and severity of cardiovascular disease (n = 1350; p all < 0.05).